Portacath Implantation in Ghana: Initial Experience at the Komfo Anokye Teaching Hospital in Kumasi
No Thumbnail Available
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Sage
Abstract
Current practice for chemotherapy in most oncology departments is the use of dedicated venous access for the continuous and frequent delivery of drugs, fluids and blood products, and the monitoring of the effects of treatment. The frequent venipuncture of peripheral veins is associated with various complications and discomfort to the patients. Permanent central venous access is therefore very important. Totally Implantable Vascular Access Device (TIVAD) is a type of central venous access that utilizes the central veins; the internal jugular vein, the subclavian or the femoral veins. It is a kind of permanent central venous access where a central venous catheter is connected to a subcutaneously buried port or septum which can be accessed at any time and has the ability to stay for almost 5 years. They are therefore the preferred form of long-term central venous access in patients treated by oncology departments. We share our initial experience of 5 patients in our institution. There were 4 females and one young boy who had been diagnosed with Hemophilia. Three of the patients had new implantation, one had removal of her 5-year-old TIVAD that had been implanted in another country and one had the TIVAD accessed when she had been referred to our hospital for breast surgery after neoadjuvant chemotherapy.
Description
Keywords
Citation
Okyere I, Okyere P, Singh S, Brenu SG. Portacath Implantation in Ghana: Initial Experience at the Komfo Anokye Teaching Hospital in Kumasi. Clinical Medicine Insights: Case Reports. 2022;15. doi:10.1177/11795476221087910